adenosine 2',5'-diphosphate has been researched along with dalteparin in 1 studies
*Dalteparin: A low-molecular-weight fragment of heparin, prepared by nitrous acid depolymerization of porcine mucosal heparin. The mean molecular weight is 4000-6000 daltons. It is used therapeutically as an antithrombotic agent. (From Merck Index, 11th ed) [MeSH]
*Dalteparin: A low-molecular-weight fragment of heparin, prepared by nitrous acid depolymerization of porcine mucosal heparin. The mean molecular weight is 4000-6000 daltons. It is used therapeutically as an antithrombotic agent. (From Merck Index, 11th ed) [MeSH]
Studies (adenosine 2',5'-diphosphate) | Trials (adenosine 2',5'-diphosphate) | Recent Studies (post-2010) (adenosine 2',5'-diphosphate) | Studies (dalteparin) | Trials (dalteparin) | Recent Studies (post-2010) (dalteparin) |
---|---|---|---|---|---|
29 | 0 | 2 | 5,665 | 1,423 | 2,267 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Heptinstall, S; May, JA; Storey, RF | 1 |
1 other study(ies) available for adenosine 2',5'-diphosphate and dalteparin
Article | Year |
---|---|
Potentiation of platelet aggregation by heparin in human whole blood is attenuated by P2Y12 and P2Y1 antagonists but not aspirin.
Topics: Adenosine Diphosphate; Adenosine Monophosphate; Aspirin; Blood Platelets; Cell Degranulation; Dalteparin; Drug Synergism; Heparin; Hirudins; Humans; In Vitro Techniques; Membrane Proteins; Platelet Aggregation; Platelet Aggregation Inhibitors; Purinergic P2 Receptor Antagonists; Receptors, Purinergic P2Y1; Receptors, Purinergic P2Y12 | 2005 |